[Acute coronary syndrome. The second platelet inhibitor is self-paid].
D000208:Acute Disease; D000789:Angina, Unstable / Q000188:drug therapy*; D001241:Aspirin / Q000008:administration & dosage* / Q000191:economics* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D000077144:Clopidogrel; D003362:Cost-Benefit Analysis; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000191:economics* / Q000627:therapeutic use; D012307:Risk Factors; D013988:Ticlopidine / Q000008:administration & dosage* / Q000031:analogs & derivatives / Q000191:economics* / Q000627:therapeutic use
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin